Loading...
Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up
Although fluoroquinolones are first-line agents for the treatment of National Institutes of Health (NIH) category II chronic bacterial prostatitis (CBP), therapy with these agents is not always feasible due to the increasing worldwide resistance of causative uropathogens. New therapeutic options are...
Na minha lista:
| Udgivet i: | Exp Ther Med |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5038489/ https://ncbi.nlm.nih.gov/pubmed/27698761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3631 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|